High concentrations of phosphate, oxalate, and calcium ions in urine may cause formation of mineral deposits, i.e., urolithiasis. This is prevented in healthy individuals by substances present in trace quantities. However, there is no recognizable difference between normals and stone formers in urinary substance content. The enzymes glutamic oxaloacetic transaminase and glutamic pyruvic transaminase produce glutamic acid which retards calcium oxalate crystallization. The combined transaminase activity in 70 stone former urine samples was 12.2 ± 4.1 IU and 31.9 ± 10.7 IU for 47 normal controls. Incubation of stone former urine with glutamic oxaloacetic transaminase improved overall inhibitory potential, raised glutamic acid levels, and decreased aspartic acid concentrations. Correlation was established between the success of therapeutic treatment and the improvement of enzyme activity. The relative content of glutamic acid is low in stone former urines and high in active inhibitory fractions of urinary materials. It is suggested that part of the mechanisms of prevention of stone formation is subjected to biological control.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.